Prevention of migraine with monoclonal antibodies against CGRP or the CGRP receptor: Addition to the S1 guideline: Therapy of migraine attacks and prevention of migraine. Recommendations of the Germany Society of Neurology and the German Migraine and Headache Society

Monoclonal antibodies against the calcitonin gene-related peptide (CGRP) receptor (Erenumab) or against CGRP (Eptinezumab, Fremanezumab, Galcanezumab) are new substances for the preventive treatment of migraine. They represent an extension of the therapeutic options, which already exist in migraine...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurol Res Pract
Main Authors: Diener, Hans-Christoph, Förderreuther, Stefanie, Gaul, Charly, Giese, Florian, Hamann, Till, Holle-Lee, Dagny, Jürgens, Tim P., Kamm, Katharina, Kraya, Torsten, Lampl, Christian, May, Arne, Reuter, Uwe, Scheffler, Armin, Tfelt-Hansen, Peer
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Guideline
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650107/
https://ncbi.nlm.nih.gov/pubmed/33324917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s42466-020-00057-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados